1. Home
  2. PRE

as of 09-04-2026 3:43pm EST

$25.43
$0.62
-2.38%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.

Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 301.5M IPO Year: 2021
Target Price: $30.50 AVG Volume (30 days): 260.7K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $9.29 - $27.24 Next Earning Date: 06-11-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 108.69% Revenue Growth (next year): 58.68%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Stock Insider Trading Activity of Prenetics Global Limited (PRE)

Rosin Brian J

CFO of IM8 (US) LLC

Buy
PRE Aug 25, 2026

Avg Cost/Share

$22.80

Shares

5,100

Total Value

$116,280.00

Owned After

23,100

SEC Form 4

Yeung Danny Sheng Wu

Chief Executive Officer

Buy
PRE Aug 24, 2026

Avg Cost/Share

$21.15

Shares

17,181

Total Value

$364,673.40

Owned After

101,235

Rosin Brian J

CFO of IM8 (US) LLC

Buy
PRE Aug 24, 2026

Avg Cost/Share

$21.19

Shares

18,000

Total Value

$381,420.00

Owned After

23,100

SEC Form 4

Yeung Danny Sheng Wu

Chief Executive Officer

Buy
PRE Aug 20, 2026

Avg Cost/Share

$18.31

Shares

7,500

Total Value

$137,325.00

Owned After

101,235

SEC Form 4

Share on Social Networks: